A Doody's Core Title 2012
Emerging Cancer Therapeutics is a trinary, hard cover, periodical that is designed to provide an up-to-date evidence-based review of a dedicated emerging cancer therapy topic of interest to clinicians and scientists who are involved in the care of patients receiving cancer treatment. It will serve as both a reference and instructional tool for students, housestaff, fellows, practicing clinical oncologists, radiation oncologists, surgical oncologists, cancer biologists, and interdisciplinary colleagues throughout the oncology spectrum.
With contributions from experts across the United States and Canada, Prostate Cancer details the current management of prostate cancer and reviews new therapies in development for prostate cancer, with an emphasis on castration-resistant prostate cancer (CRPC). Coverage includes discussion of multiple new agents that have been shown to impact overall survival or improve skeletal-related events in metastatic CRPC as well as articles covering new data on screening and prevention, integration of surgery and radiation with newly emerging medical therapies, and coverage of the newest developments in immunotherapy. This book is a valuable tool for clinicians, nurses, researchers, medical students, residents, and fellows.
Included in Prostate Cancer:
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
James Gulley, MD, PhD, FACP Director, Clinical Immunotherapy Group, Senior Investigator, National Cancer Institute Jame Abraham, MD Bonnie Wells Wilson Distinguished Professor and Eminent Scholar, Chief, Section of Hematology-Oncology, Medical Director, Mary Babb Randolph Cancer Center West Virginia University
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.
Da: Basi6 International, Irving, TX, U.S.A.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Codice articolo ABEOCT25-230357
Quantità: 8 disponibili
Da: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Codice articolo ABNR-55349
Quantità: 5 disponibili
Da: BOOKWEST, Phoenix, AZ, U.S.A.
Hardcover. Condizione: New. 1st Edition. SHRINK-WRAPPED: US SELLER SHIPS FROM USA. Codice articolo ORD3-S0-HC-1936287463-1P3-B10-BRN-2011
Quantità: 1 disponibili
Da: SMASS Sellers, IRVING, TX, U.S.A.
Condizione: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed. Codice articolo ASNT3-55349
Quantità: 5 disponibili
Da: ALLBOOKS1, Direk, SA, Australia
Brand new book. Fast ship. Please provide full street address as we are not able to ship to P O box address. Codice articolo SHAK230357
Quantità: 8 disponibili
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. pp. 200. Codice articolo 2614285273
Quantità: 4 disponibili
Da: Majestic Books, Hounslow, Regno Unito
Condizione: New. pp. 200. Codice articolo 11421190
Quantità: 4 disponibili
Da: Biblios, Frankfurt am main, HESSE, Germania
Condizione: New. pp. 200. Codice articolo 1814285267
Quantità: 4 disponibili
Da: Grand Eagle Retail, Bensenville, IL, U.S.A.
Hardcover. Condizione: new. Hardcover. Emerging Cancer Therapeutics is a trinary, hard cover, periodical that is designed to provide an up-to-date evidence-based review of a dedicated emerging cancer therapy topic of interest to clinicians and scientists who are involved in the care of patients receiving cancer treatment. It will serve as both a reference and instructional tool for students, house staff, fellows, practising clinical oncologists, radiation oncologists, surgical oncologists, cancer biologists, and interdisciplinary colleagues throughout the oncology spectrum. With contributions from experts across the United States and Canada, Prostate Cancer details the current management of prostate cancer and reviews new therapies in development for prostate cancer, with an emphasis on castration-resistant prostate cancer (CRPC). Coverage includes discussion of multiple new agents that have been shown to impact overall survival or improve skeletal-related events in metastatic CRPC as well as articles covering new data on screening and prevention, integration of surgery and radiation with newly emerging medical therapies, and coverage of the newest developments in immunotherapy. This book is a valuable tool for clinicians, nurses, researchers, medical students, residents, and fellows. Included in Prostate Cancer: Updates in Prostate Cancer Prevention Prostate Cancer Screening, 2011 Current Surgical Approaches to Primary Prostate Cancer Treatment Updates in Radiation Therapy for Prostate Cancer: Dose Matters An Update on Androgen-Deprivation Therapy for Advanced Prostate Cancer Novel Androgen Receptor Therapeutic Targets for Advanced Prostate Cancer New Understanding of Metabolic Complications of Androgen-Deprivation Therapy Current State of Docetaxel-Based Therapy in Castration-Resistant Prostate Cancer Second-Line Chemotherapy for Castration-Resistant Prostate Cancer Emerging Role of Immunotherapy in the Treatment of Prostate Cancer Novel Bone-Targeted Therapy in Metastatic Prostate Cancer Emerging Treatment Strategies for Metastatic Prostate Cancer: The Next Step Forward Prostate cancer treatment has undergone major changes over the course of the past few years and the pace of new research and development is expected to continue at a high level for the immediate future. This title provides a comprehensive review for practitioners on the status of prostate cancer treatment. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Codice articolo 9781936287468
Quantità: 1 disponibili
Da: Hay-on-Wye Booksellers, Hay-on-Wye, HEREF, Regno Unito
Condizione: As New. Codice articolo HP-11413
Quantità: 1 disponibili